Adapted from NICE: Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. May 2008 (reissued March 2010).
To view the chart above, you require Flash.
To print: right-click (Windows) or ctrl + click (Macintosh) on the chart and select 'Print...' from the menu.
| BOX 1 |
|---|
Clinical Assessment - BP
- BMI
- Fasting blood glucose
- Renal function
- Liver function
- TSH if dyslipidaemia is present
- Smoking status
- Alcohol consumption
- Fasting TC, LDL-C, HDL-C and triglycerides (if not already available)
| Lifestyle Advice - Diet and weight
- Physical activity
- Alcohol reduction
- Smoking cessation
|
BOX 2: RISK ESTIMATION
|
|---|
Risk (including Framingham, ASSIGN and QRISK equations should not be used for people already considered at high risk of CVD – use clinical assessment instead. The Framingham equations may overestimate risk in UK populations. When using these equations, multiply the score by: - 1.4 for men with a South Asian background
- 1.5 if one relative has a history of premature CHD†
- 1.5 to 2.0 if two or more relatives have a history of premature CHD†
Click here for Framingham CHD risk calculator |
Full NICE guideline
KEYWORDS: Acute coronary syndrome | Cardiovascular risk assessment | Lipid modification | Primary prevention of CVD | Secondary prevention of CVD | Statins
